Report for Pari Raj(22Y/M)

Aditya Raj(26Y/M)

Tests asked Comprehensive Full Body Checkup With Vitamin D And B12 - 3, Phos

Test date 25 Oct 2025 Report status Complete Report

Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : ADITYA RAJ(26Y/M)

PARI RAJ(22Y/M) Tests Done : Comprehensive Full Body Checkup With
Referred By : SELF Vitamin D and B12 - 3,PHOS

Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF
POWER GRID HIGH MONT ROAD WAKAD PUNE

Report Availability Summary

Note: Please refer to the table below for status of your tests.

12 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

PHOSPHOROUS Ready

Comprehensive Full Body Checkup With Vitamin D and B12 - 3 Ready

FASTING BLOOD SUGAR(GLUCOSE) Ready

25-OH VITAMIN D (TOTAL) Ready

IRON Ready

VITAMIN B-12 Ready

COMPLETE URINE ANALYSIS Ready

HBA PROFILE Ready

HEMOGRAM - 6 PART (DIFF) Ready

LIVER FUNCTION TESTS Ready

KIDPRO Ready

LIPID PROFILE Ready

T3-T4-USTSH Ready
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : ADITYA

PARI RAJ(22Y/M)
RAJ(26Y/M) Tests Done : Comprehensive Full Body Checkup With
Referred By : SELF Vitamin D and B12 - 3,PHOS

Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF
POWER GRID HIGH MONT ROAD WAKAD PUNE

Tests Outside Reference Range

Note: Please refer to the table below for tests outside reference range.

Test Name Observed Value Units Bio. Ref. Interval.

COMPLETE HEMOGRAM
HEMATOCRIT(PCV) 52.8 % 40.0-50.0

MEAN PLATELET VOLUME(MPV) 12.9 fL 6.5-12

PLATELET DISTRIBUTION WIDTH(PDW) 17.6 fL 9.6-15.2

PLATELET TO LARGE CELL RATIO(PLCR) 47.9 % 19.7-42.4

TOTAL RBC 5.85 X 10^6/µL 4.5-5.5

LIPID
HDL / LDL RATIO 0.29 Ratio > 0.40

HDL CHOLESTEROL - DIRECT 40 mg/dL 40-60

LDL CHOLESTEROL - DIRECT 136.5 mg/dL < 100

TRIG / HDL RATIO 3.85 Ratio < 3.12

TRIGLYCERIDES 152 mg/dL < 150

LIVER
ALANINE TRANSAMINASE (SGPT) 109.6 U/L < 45

ASPARTATE AMINOTRANSFERASE (SGOT ) 66.5 U/L < 35

BILIRUBIN (INDIRECT) 1.68 mg/dL 0-0.9

BILIRUBIN - TOTAL 1.99 mg/dL 0.3-1.2

BILIRUBIN -DIRECT 0.31 mg/dL < 0.3

SERUM GLOBULIN 2.41 gm/dL 2.5-3.4

RENAL
CALCIUM 8.34 mg/dL 8.8-10.6

THYROID
TSH - ULTRASENSITIVE 5.47 µIU/mL 0.35-4.94

VITAMIN
25-OH VITAMIN D (TOTAL) 22.17 ng/mL 30-100

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values, parameter correlation and clinical
interpretation, kindly refer to the same in subsequent pages.
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : PARI RAJ(22Y/M)

ADITYA RAJ(26Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 11:53
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 13:42
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : EDTA Whole Blood | ET937053

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c H.P.L.C 5 %
Bio. Ref. Interval. :
As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control
5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 97 mg/dL

Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values

Please correlate with clinical conditions.

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd-NABL

Scan QR to verify(valid for
accredited, NABL certificate no: MC-5319 Dr Zeeshan Hashmi
30 days from release time)
MD(Path)

Page : 1 of 14
Processed At :

Sohrabh Hall, 112, A Wing, 1st

Floor, Sangamwadi, Pune 411001

Patient Name : ADITYA RAJ(26Y/M)

PARI RAJ(22Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 11:53
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 13:42
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : EDTA Whole Blood | ET937053

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 16.8 g/dL 13.0-17.0
Hematocrit (PCV) CPH Detection 52.8 % 40.0-50.0
Total RBC HF & EI 5.85 X 10^6/µL 4.5-5.5
Mean Corpuscular Volume (MCV) Calculated 90.3 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 28.7 pq 27.0-32.0
Mean [Link]. Conc (MCHC) Calculated 31.8 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 41.9 fL 39-46
Red Cell Distribution Width (RDW - CV) Calculated 12.7 % 11.6-14
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 196 - *Refer Note below
MENTZER INDEX Calculated 15.4 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 7.01 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 57.9 % 40-80
Lymphocytes Percentage Flow Cytometry 33 % 20-40
Monocytes Percentage Flow Cytometry 4.3 % 2-10
Eosinophils Percentage Flow Cytometry 4 % 1-6
Basophils Percentage Flow Cytometry 0.7 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.1 % 0-0.5
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 4.06 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 2.31 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.3 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.05 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.28 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.01 X 10³ / µL 0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 194 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 12.9 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 17.6 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 47.9 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.25 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta Thalassemia Trait (BTT).
MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely to be BTT. Suggested Clinical correlation. BTT to be
confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd

Dr Zeeshan Hashmi
MD(Path)

Page : 2 of 14
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : PARI

ADITYA RAJ(26Y/M)
RAJ(22Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 12:02
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 12:49
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : FLUORIDE PLASMA | EY517463

TEST NAME TECHNOLOGY VALUE UNITS

FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 92.65 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Fasting Plasma Glucose (FPG)

Normal 70 to 100 mg/dl

Prediabetes 100 mg/dl to 125 mg/dl

Diabetes 126 mg/dl or higher

Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.
Please correlate with clinical conditions.
Method:- GOD-POD METHOD

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd-NABL

accredited, NABL certificate no: MC-5319 Dr Zeeshan Hashmi
MD(Path)

Page : 3 of 14
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : ADITYA RAJ(26Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 12:05
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 14:19
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : URINE | ER869734

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

Complete Urinogram
Physical Examination
VOLUME Visual Determination 3 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change 1.02 - 1.003-1.030
PH pH indicator 5.5 - 5-8
Chemical Examination
URINARY PROTEIN PEI ABSENT mg/dL Absent
URINARY GLUCOSE GOD-POD ABSENT mg/dL Absent
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
BILE SALT Hays sulphur ABSENT - Absent
BILE PIGMENT Ehrlich reaction ABSENT - Absent
URINE BLOOD Peroxidase reaction ABSENT - Absent
NITRITE Diazo coupling ABSENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
MUCUS Microscopy ABSENT - Absent
RED BLOOD CELLS Microscopy ABSENT cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5
EPITHELIAL CELLS Microscopy ABSENT cells/HPF 0-5
CASTS Microscopy ABSENT - Absent
CRYSTALS Microscopy ABSENT - Absent
BACTERIA Microscopy ABSENT - Absent
YEAST Microscopy ABSENT - Absent
PARASITE Microscopy ABSENT - Absent
(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd

Dr Zeeshan Hashmi
MD(Path)

Page : 4 of 14
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : PARI

ADITYA RAJ(26Y/M)
RAJ(22Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 12:12
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 18:36
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : SERUM | EH574208

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) C.L.I.A 22.17 ng/mL
Bio. Ref. Interval. :-

DEFICIENCY : <20 ng/ml || INSUFFICIENCY : 20-<30 ng/ml

SUFFICIENCY : 30-100 ng/ml || TOXICITY : >100 ng/ml

Clinical Significance:

Vitamin D is a fat-soluble vitamin that has been known to help the body absorb and retain calcium and phosphorus; both are
critical for building bone health. Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency,
nephrotic syndrome. Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml.

Kit Validation Reference: Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.

Please correlate with clinical conditions.

Method:- Fully Automated Chemi Luminescent Immuno Assay

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd-NABL

accredited, NABL certificate no: MC-5319 Dr Zeeshan Hashmi
MD(Path)

Page : 5 of 14
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : PARI

ADITYA RAJ(26Y/M)
RAJ (22Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 12:12
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 18:36
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : SERUM | EH574208

TEST NAME TECHNOLOGY VALUE UNITS

VITAMIN B-12 C.L.I.A 333 pg/mL
Bio. Ref. Interval. :-

Normal : 211 - 911 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat,
eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin
sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic
anemias. For diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical
examination and other findings.

Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml

Kit Validation reference:

Chen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St. Louis: CV Mosby;
1987:569–73.

Please correlate with clinical conditions.

Method:- COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd-NABL

accredited, NABL certificate no: MC-5319 Dr Zeeshan Hashmi
MD(Path)

Page : 6 of 14
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : PARI

ADITYA RAJ(26Y/M)
RAJ (22Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 12:12
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 18:36
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : SERUM | EH574208

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 187 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 40 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 136.5 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 152 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 4.7 Ratio 3-5
TRIG / HDL RATIO CALCULATED 3.85 Ratio < 3.12
LDL / HDL RATIO CALCULATED 3.5 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.29 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 147.1 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 30.48 mg/dL 5 - 40

Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd-NABL

accredited, NABL certificate no: MC-5319 Dr Zeeshan Hashmi
MD(Path)

Page : 7 of 14
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : ADITYA RAJ(26Y/M)

PARI RAJ (22Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 12:12
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 18:36
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : SERUM | EH574208

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 125.4 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 1.99 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.31 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 1.68 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 32.3 U/L < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 66.5 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 109.6 U/L < 45
SGOT / SGPT RATIO CALCULATED 0.61 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 6.63 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.22 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.41 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.75 Ratio 0.9 - 2

Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd-NABL

accredited, NABL certificate no: MC-5319 Dr Zeeshan Hashmi
MD(Path)

Page : 8 of 14
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : PARI

ADITYA RAJ(26Y/M)
RAJ (22Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 12:12
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 18:36
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : SERUM | EH574208

TEST NAME TECHNOLOGY VALUE UNITS

PHOSPHOROUS PHOTOMETRY 3.74 mg/dL
Bio. Ref. Interval. :
Adults : 2.4 - 5.1 mg/dL
Children : 4.0 - 7.0 mg/dL

Clinical Significance:
In plasma and serum the majority of phosphate exists in the inorganic form (Pi), approximately 15% bound to protein and the
remainder in complexes and free forms. Serum phosphate concentrations are dependent on diet and variation in the secretion of
hormones such as Parathyroid Hormone (PTH).

Specifications:
Precision %CV :- Intra assay %CV- 1.55% , Inter assay %CV-2.99% , Sensitivity:-0.10 mmol/L

Kit Validation Reference:

Young DS. Effects of drugs on clinical laboratory tests, 5th ed. AACC Press, 2000.
Method : UNREDUCED PHOSPHOMOLYBDATE METHOD

Please correlate with clinical conditions.

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd-NABL

accredited, NABL certificate no: MC-5319 Dr Zeeshan Hashmi
MD(Path)

Page : 9 of 14
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : ADITYA RAJ(26Y/M)

PARI RAJ (22Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 12:12
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 18:36
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : SERUM | EH574208

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 172 µg/dL
Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170
Method : Ferrozine method without deproteinization

Please correlate with clinical conditions.

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd-NABL

accredited, NABL certificate no: MC-5319 Dr Zeeshan Hashmi
MD(Path)

Page : 10 of 14
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : PARI

ADITYA RAJ(26Y/M)
RAJ (22Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 12:12
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 18:36
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : SERUM | EH574208

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 9.96 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 0.74 mg/dL 0.72-1.18
BUN / [Link] RATIO CALCULATED 13.46 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 21.31 mg/dL Adult : 17-43
UREA / [Link] RATIO CALCULATED 28.8 Ratio < 52
CALCIUM PHOTOMETRY 8.34 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 4.9 mg/dL 4.2 - 7.3

Please correlate with clinical conditions.

Method :
BUN - Kinetic UV Assay.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and [Link] values.
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd

Dr Zeeshan Hashmi
MD(Path)

Page : 11 of 14
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : PARI

ADITYA RAJ(26Y/M)
RAJ (22Y/M) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 12:12
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 18:36
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : SERUM | EH574208

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 142 ng/dL 58-159

TOTAL THYROXINE (T4) C.M.I.A 8.96 µg/dL 4.87-11.72

TSH - ULTRASENSITIVE C.M.I.A 5.47 µIU/mL 0.35-4.94

The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3,T4,USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd-NABL

accredited, NABL certificate no: MC-5319 Dr Zeeshan Hashmi
MD(Path)

Page : 12 of 14
Processed At :
Sohrabh Hall, 112, A Wing, 1st
Floor, Sangamwadi, Pune 411001

Patient Name : PARI

ADITYA RAJ(26Y/M)
RAJ(22M/Y) Sample Collected on (SCT) : 25 Oct 2025 07:45
Referred By : SELF Sample Received on (SRT) : 25 Oct 2025 12:12
Home Collection : A-1104 A WING HIGH MONT SOCIETY BESIDE INFOSYS FRONT OF Report Released on (RRT) : 25 Oct 2025 18:36
POWER GRID HIGH MONT ROAD WAKAD PUNE Sample Type | Barcode : SERUM | EH574208

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 128 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- 2021 CKD EPI Creatinine Equation

~~ End of report ~~

Tests Done : Comprehensive Full Body Checkup With Vitamin D and

B12 - 3,PHOSPHOROUS

Report Remarks : Clinically Tested by: Thyrocare Technologies Ltd-NABL

Scan QR to verify(valid for
accredited, NABL certificate no: MC-5319 Dr Zeeshan Hashmi
30 days from release time)
MD(Path)

Page : 13 of 14
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Docon Technologies Private Limited,Thyrocare Technologies Limited and its employees/representatives do not
assume any liability,responsibility for any loss or damage that may be incurred by any person as a result of
presuming the meaning or contents of the report.

EXPLANATIONS
v Name - The name is as declared by the client and recorded by the personnel who collected the specimen.
v [Link] - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing the
barcode (irrespective of the name).
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v For suggestions, complaints or feedback, write to us at grievance-office@[Link] or call us on 7022000900.

Page : 14 of 14